Wearable Cardioverter-Defibrillator Therapy for the Prevention of Sudden Cardiac Death
Published: March 28, 2016
![Science News on light gray background](/-/media/PHD-Images/Science-News/science_news_default.jpg?h=343&iar=0&mh=515&mw=515&w=515)
- Wearable cardioverter defibrillators (WCDs) have emerged as a bridge to permanent device implantation in certain patients at risk for sudden cardiac death (SCD).
- Though the use of WCDs has been increasing, there has been continued uncertainty regarding appropriate indications for this therapy.
- This advisory aims to provide comprehensive review, assessment, and guidance regarding WCD therapy in contemporary clinical practice.